单位：[1]Department of Traditional and Western Medical Hepatology, The Third Hospital of Hebei Medical University, Shijiazhuang 050051, China[2]Department of Infectious Diseases, Inner Mongolia Autonomous Region People’s Hospital, Hohhot, Inner Mongolia 010017, China[3]Department of Hepatology, Hangzhou Xixi Hospital, Hangzhou 310023, China[4]Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Peking University Hepatology Institute, Peking University People’s Hospital, Beijing 100044, China[5]Artificial Liver Centre, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China[6]Centre for Hepatology and Gastroenterology, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China[7]Department of Infectious Diseases, Shengjing Hospital of China Medical University, Shenyang 110022, China中国医科大学附属盛京医院[8]Artificial Liver Centre, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China[9]Department of Gastroenterology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China[10]Department of Hepatology, The First Hospital of Jilin University, Changchun 130021, China[11]Department of Hepatology and Gastroenterology, Tianjin Third Central Hospital, Tianjin 300170, China[12]Department of Gastroenterology, The First Affiliated Hospital of Air Force Medical University, Xi’an 710032,China[13]Department of Infectious Diseases, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China[14]Department of Infectious Diseases, Xiangya Hospital, Central South University, Changsha 410008, China[15]Hepatopancreatobiliary Centre, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing 102218, China[16]Liver Research Centre, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China首都医科大学附属北京友谊医院[17]Liver Diseases Research Centre, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350001, China[18]Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan 430060, China[19]Department of Microbiology, Peking University Health Science Centre, Beijing 100191, China[20]State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China浙江大学医学院附属第一医院[21]Department of Infectious Diseases, The Second Hospital of Dalian Medical University, Dalian116027, China[22]Department of Infectious Diseases, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081,China[23]Radiation Oncology Centre, The Fifth Medical Centre of Chinese PLA General Hospital, Beijing 100039, China[24]Department of Infectious Diseases, the General Hospital of Ningxia Medical University, Yinchuan 750004, China[25]Department of Infectious Diseases, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China[26]Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, China[27]Department of Infectious Diseases, Hangzhou Xixi Hospital, Hangzhou 310023, China[28]Department of Gastroenterology, First People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China[29]Department of Liver Diseases, The Fourth People’s Hospital of Qinghai Province, Xining 810001, China[30]Department of Infectious Diseases, Guizhou Provincial People’s Hospital, Guiyang 550002, China[31]Department of Gastroenterology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Digestive Diseases, Shanghai 200001, China[32]Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Peking University Hepatology Institute, Peking University People’s Hospital, Beijing 100044, China[33]The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China[34]Department of Infectious Diseases, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, China[35]Department of Infectious Diseases, Henan Province People’s Hospital, Zhengzhou University People’s Hospital and Henan University People’s Hospital, Zhengzhou 450003, China[36]Department of Infectious Diseases, People’s Hospital of Tibet Autonomous Region, Lhasa 850000, China[37]Department of Infectious Diseases, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China[38]Department of Gastroenterology, First Affiliated Hospital, China Medical University, Shenyang 110001, China[39]Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, Shijiazhuang 050051, China[40]Hepatopancreatobiliary Centre, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing 102218, China[41]Department of Gastroenterology, The Second Affiliated Hospital of Nanchang University, Nanchang 330008, China[42]Department of Infectious Diseases, Hainan General Hospital, Haikou 570311, China[43]Department of Gastroenterology, Beijing Friendship Hospital of Capital Medical University, Beijing Key Laboratory for Precancerous Lesion of Digestive Diseases, Beijing 100050, China临床科室国家中心消化分中心消化内科首都医科大学附属北京友谊医院[44]Liver Failure Treatment and Research Centre, The Fifth Medical Centre of Chinese PLA General Hospital, Beijing 100039, China[45]Centre for Liver Diseases Division 3, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China[46]Department of Infectious Diseases, Peking University First Hospital, Beijing 100034, China[47]Department of Hepatology and Gastroenterology, Qilu Hospital, Shandong University, Jinan 250012, China[48]Tianjin Second People's Hospital, Tianjin 300192, China[49]Department of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming 650000, China[50]Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu 610041, China四川大学华西医院[51]Department of Hepatology, Nanjing Hospital Affiliated to Nanjing University of Chinese Medicine and Nanjing Second Hospital, Nanjing 210003, China[52]Department of Infectious Diseases, Peking University First Hospital, Beijing 100034, China[53]Department of Infectious Diseases, The First Hospital of Shanxi Medical University, Taiyuan 030001, China[54]Department of Hepatology, Lanzhou University Second Hospital, Lanzhou 730030, China[55]Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China[56]Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, Shijiazhuang 050051, China[57]Centre for Infectious Diseases, The First Affiliated Hospital of Xinjiang Medical University, Wulumuqi 830000, China[58]Centre for Pathological Diagnosis and Research, The Fifth Medical Centre of PLA General Hospital (Beijing 302 Hospital), Beijing 100039, China[59]Department of Infectious Diseases, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233000, China[60]Liver Research Centre, The Fifth Hospital of Shijiazhuang, Shijiazhuang 050021, China[61]Department of Gastroenterology, Guangzhou First People's Hospital, Guangzhou 510181, China[62]Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou 730000, China[63]Department of Microbiology and Centre for Infectious Diseases, Peking University Health Science Centre, Beijing 100191, China[64]Department of Infectious Diseases, The First Affiliated Hospital of Shihezi University School of Medicine, Xinjiang Uygur Autonomous Region 832000, China[65]Department of Infectious Diseases, Peking University First Hospital, Beijing 100034, China[66]Storr Liver Centre, The Westmead Institute for Medical Research, The University of Sydney at Westmead Hospital, Westmead NSW 2145, Australia
Fatty liver disease associated with metabolic dysfunction is of increasing concern in mainland China, the world's most populous country. The incidence of fatty liver disease is highest in China, surpassing the incidence in European countries and the USA. An international consensus panel recently published an influential report recommending a novel definition of fatty liver disease associated with metabolic dysfunction. This recommendation includes a switch in name from non-alcoholic fatty liver disease (NAFLD) to metabolic (dysfunction)-associated fatty liver disease (MAFLD) and adoption of a set of positive criteria for disease diagnosis that are independent of alcohol intake or other liver diseases. Given the unique importance of this proposal, the Chinese Society of Hepatology (CSH) invited leading hepatologists and gastroenterologists representing their respective provinces and cities to reach consensus on alternative definitions for fatty liver disease from a national perspective. The CSH endorses the proposed change from NAFLD to MAFLD (supported by 95.45% of participants). We expect that the new definition will result in substantial improvements in health care for patients and advance disease awareness, public health policy, and political, scientific and funding outcomes for MAFLD in China. (C) 2021 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
第一作者单位：[1]Department of Traditional and Western Medical Hepatology, The Third Hospital of Hebei Medical University, Shijiazhuang 050051, China[*2]Department of Traditional and Western Medical Hepatology, The Third Hospital of Hebei Medical University, Shijiazhuang 050051, China
共同第一作者：
通讯作者：
通讯机构：[1]Department of Traditional and Western Medical Hepatology, The Third Hospital of Hebei Medical University, Shijiazhuang 050051, China[16]Liver Research Centre, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China[65]Department of Infectious Diseases, Peking University First Hospital, Beijing 100034, China[66]Storr Liver Centre, The Westmead Institute for Medical Research, The University of Sydney at Westmead Hospital, Westmead NSW 2145, Australia[*1]Department of Infectious Diseases, Peking University First Hospital, Beijing 100034, China[*2]Department of Traditional and Western Medical Hepatology, The Third Hospital of Hebei Medical University, Shijiazhuang 050051, China[*3]Storr Liver Centre, The Westmead Institute for Medical Research, The University of Sydney at Westmead Hospital, Westmead NSW 2145, Australia
推荐引用方式(GB/T 7714)：
Yuemin Nan,Jihong An,Jianfeng Bao,et al.The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease[J].JOURNAL of HEPATOLOGY.2021,75(2):454-461.doi:10.1016/j.jhep.2021.05.003.
APA：
Yuemin Nan,Jihong An,Jianfeng Bao,Hongsong Chen,Yu Chen...&Liang Qiao.(2021).The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease.JOURNAL of HEPATOLOGY,75,(2)
MLA：
Yuemin Nan,et al."The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease".JOURNAL of HEPATOLOGY 75..2(2021):454-461
医学